›Portfolio Companies

Past, Present and Future Leaders

InterWest is proud and privileged to partner with visionary management teams who are shaping the future of Information Technology and Healthcare. The companies they have started are vital parts of the portfolio of industry-leading startups that InterWest has helped over the last four decades.

Our Companies

Early stage IT and Healthcare Investing

Gil Kliman


General Partner

"It’s a privilege to work with visionary entrepreneurs who are creating the technologies and procedures that define the future of medical care. And it’s exciting to help them craft business strategies that propel and transform their ideas into market penetration and real-world success."

InterWest Team

Current Investments

Prior Investments

Gil's bio

Company News


Gil's Latest Buzz

Gil's video

Gil joined InterWest's healthcare team in 1996. He invests in a broad array of healthcare opportunities, focusing on medical devices and healthcare IT, with a special interest in ophthalmology. He is a board member of Autonomic Technologies, BenvenueDoximity, Glaukos, GobiquityRestoration Robotics, and ReVision Optics

Gil has led InterWest's medical device team since 1999 and pioneered InterWest's ophthalmology franchise. He was an early investor in IntraLase and LenSx, category-creating ophthalmic laser companies that became standard-of-care devices for eye surgery around the world, while realizing high-value exits in two prior InterWest funds. Gil is also a successful healthcare IT investor, building this important franchise for InterWest over the last fifteen years through multiple companies. He led the Series A of Epocrates, the industry-leading first mobile application for physicians, serving on the board through its 2011 IPO. 

Prior to InterWest, Gil was a health care investor at TA Associates and at Norwest Venture Capital. A former practicing ophthalmologist and laser researcher, he was previously West Coast director of LCA Vision, and served as an assistant professor at Tufts New England Eye Center and on the clinical faculty at Massachusetts Eye and Ear Infirmary.

Gil has a B.A. from Harvard University. He received an M.D. from the University of Pennsylvania and an M.B.A. from Stanford University. He completed an ophthalmology residency at Wills Eye Institute and retina fellowship at Massachusetts Eye and Ear Infirmary as a Heed Foundation Fellow. He also serves as a National Trustee for the Foundation Fighting Blindness.

Prior Investments

Epocrates (Acquired by Athena Health in 2013),  INC Research (Acquired by Avista Capital Partners in 2010), Inspire Pharmaceuticals (IPO 2000, ISPH) IntraLase (IPO 2004, ILSE), LenSx Lasers (Acquired by Alcon in 2010), Spinal Dynamics (Acquired by Medtronic in 2002), Spiration (Acquired by Olympus Medical Systems in 2010)

Over the last 20 years I have had the privilege of diverse life experiences as a laser researcher, practicing physician, startup company founder, and technology venture capitalist. I most enjoy being on the front edge of new technology waves, looking over the horizon for non-obvious opportunities... What I find exciting is working alongside visionary entrepreneurs, thinking non-traditionally, and helping to identify creative strategies to make pioneering ventures even more successful.

Information Technology


Facebook Google+ Twitter Email LinkedIn Share